The mean NSE levels between the groups without neurological dysfunction (Group U, n = 178) and with stroke (Group S) were not significantly different (31.8 ± 11.2 ng/ml [Group U] vs 28.5 ± 7.6 ng/ml [Group S]); p = 0.264). The gene discussed is ENO2; the disease is stroke disorder.